Form 8-K - Current report:
SEC Accession No. 0001826667-25-000014
Filing Date
2025-02-03
Accepted
2025-02-03 11:08:52
Documents
16
Period of Report
2025-01-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tlsi-20250131.htm   iXBRL 8-K 29160
2 EX-99.1 trisaluslifesciencespr-202.htm EX-99.1 12774
7 imagea.jpg GRAPHIC 20796
  Complete submission text file 0001826667-25-000014.txt   242434

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tlsi-20250131.xsd EX-101.SCH 2193
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tlsi-20250131_def.xml EX-101.DEF 15975
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tlsi-20250131_lab.xml EX-101.LAB 27896
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tlsi-20250131_pre.xml EX-101.PRE 16713
18 EXTRACTED XBRL INSTANCE DOCUMENT tlsi-20250131_htm.xml XML 4178
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Filer) CIK: 0001826667 (see all company filings)

EIN.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39813 | Film No.: 25580899
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)